e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.03p
   
  • Change Today:
      0.075p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 325,706
  • Market Cap: £58.58m

Latest Deals

Traded Action Notifier PriceAmountValue
09-Jan-24 Buy Trevor Mervyn Jones 8.28p 91,325 £7,561.71
06-Jul-23 Buy Trevor Mervyn Jones 21.71p 34,830 £7,561.59

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
09-Jan-24 Buy Trevor Mervyn Jones 8.28p 91,325 £7,561.71
06-Jul-23 Buy Trevor Mervyn Jones 21.71p 34,830 £7,561.59

Director Shareholdings

Notifier Holding Value*
Ali Mortazavi 50,941,666 £5,106,902
Trevor Mervyn Jones 1,293,896 £129,713
Michael Anthony Bretherton 500,000 £50,125

Major Shareholders

Notifier** Holding Value*
Richard Griffiths 170,510,905 £17,093,718
M&G Plc 101,875,000 £10,212,969
Robert Quested 52,000,000 £5,213,000
Trillian Ltd 29,769,326 £2,984,375
Henderson Global Investors 26,445,958 £2,651,207
David Richardson 24,779,030 £2,484,098
Lombard Odier Asset Management (Europe) Limited 20,965,820 £2,101,824
Rupert Labrum 17,162,547 £1,720,545
Gartmore Investment Limited 6,541,000 £655,735
Credit Suisse Client Nominees (UK) Limited 4,557,950 £456,934

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 10.03p
Change Today 0.075p
% Change 0.75 %
52 Week High 23.10
52 Week Low 8.13
Volume 325,706
Shares Issued 584.34m
Market Cap £58.58m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.04% below the market average24.04% below the market average24.04% below the market average24.04% below the market average24.04% below the market average
39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average
Price Trend
60.23% below the market average60.23% below the market average60.23% below the market average60.23% below the market average60.23% below the market average
29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average
Income Not Available
Growth
15.32% below the market average15.32% below the market average15.32% below the market average15.32% below the market average15.32% below the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
15:45 150,000 @ 10.14p
15:38 4,000 @ 10.17p
15:34 100,000 @ 10.19p
14:56 1,500 @ 9.60p
14:26 6,000 @ 9.60p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page